Search

everythinglearnresearchcommunity

for

Search:↓

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Male pattern baldness involves hormones and cell signals affecting hair growth.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Blocking the FGF5 gene in sheep leads to more fine wool and active hair follicles due to changes in certain cell signaling pathways.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

Androgens increase EPO production, finasteride doesn't significantly impact it.

Androgens reduce BMP2, which weakens the ability of certain cells to help hair stem cells become different types of cells.

Lower DHT and higher testosterone levels increase brain activation but don't change behavior in heavy drinkers.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Combination therapies for androgenetic alopecia are more effective, but more research is needed for safe, standardized treatments.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Androgens like testosterone may help treat traumatic brain injury by reducing mitochondrial stress and inflammation.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Androgens affect skin conditions like acne and hirsutism, treatable with hormone therapy and other methods.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Antiandrogen therapy helps treat genetic hair loss.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Antiandrogens don't help with COVID-19 and aren't recommended.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Targeting multiple pathways may improve treatments for androgenetic alopecia.